Advertisement

Uncategorized

Pennsylvania providers have reported receiving demand letters on untimed codes for therapy from DCS, the Region A RAC covering the Northeast, wrote Nancy Beckley, president of Bloomingdale Consulting Group, in the RAC Monitor.

Advertisement

The Medical Device Manufactures Association has submitted comments to CMS and the FDA concerning the jointly proposed "parallel review" process for premarket, FDA-regulated medical products, according to a news release from MDMA.

Advertisement